Correction to: Early clinical response to tofacitinib treatment as a predictor of subsequent efficacy: Results from two phase 3 studies of patients with moderate-to-severe plaque psoriasis.

Related Articles

Correction to: Early clinical response to tofacitinib treatment as a predictor of subsequent efficacy: Results from two phase 3 studies of patients with moderate-to-severe plaque psoriasis.

J Dermatolog Treat. 2017 Feb;28(1):x

Authors:

PMID: 28201942 [PubMed - in process]

http://ift.tt/2m4z69L